Merck will be making a $70 billion investment in U.S.-based research and manufacturing starting in 2025, the pharmaceutical ...

Cambrex will invest $120M to expand U.S. drug manufacturing, boosting API capacity at its Iowa site and adding jobs amid ...

Merck is breaking ground on a new 400,000-square-foot manufacturing facility in Elkton, Virginia, as part of its $70 billion ...

Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments.

Merck has kicked off construction of a new $3 billion facility at its sprawling manufacturing campus in Elkton, Virginia. | ...

It's the latest in a string of announcements by pharmaceutical manufacturers to build or expand operations in Virginia.

In a press release, Cambrex CEO Thomas Loewald calls the Charles City site the largest independent API manufacturing facility ...

Merck will invest $3 billion in a new pharmaceutical manufacturing facility in Virginia, creating 500 jobs and expanding U.S.

The FDA has declared a Novo Nordisk plant, key to drug manufacturing for some biotechs, out of compliance, which could delay ...

The Trump administration is turning to an unconventional approach to lowering drug prices in the United States: striking ...

We wanted to know where a widely used prescription drug that treats high cholesterol was manufactured and whether the factory ...